Furthermore, imatinib is used as an adjuvant therapy in patients with Gastrointestinal stromal tumour (GIST) and there are reports of imatinib treated GIST cells showing increased FAK tyrosine phosphorylation after long term treatment (6–24 hours)27, 33. The gene discussed is PTK2; the disease is gastrointestinal stromal tumor.